|
|
|
|
Timing Is Everything: Age of Onset Influences Long-term Retinopathy Risk in Type 2 Diabetes, Independent of Tr
_ Timing Is Everything: Age of Onset Influences Long-term Retinopathy Risk in Type 2 Diabetes, Independent of Tr.
|
|
|
Long-Term A1c Stability Reduces Risk of Diabetic Retinopathy, Nephropathy
_ Long-Term A1c Stability Reduces Risk of Diabetic Retinopathy, Nephropathy.
|
|
|
Blood Sugar Control Helps Diabetics Preserve Sight
FRIDAY, Nov.14 (HealthDay News) -- Maintaining good control over one's blood sugar levels can help people with type 1 diabetes better avoid retinopathy, a serious disorder that damages the eye's retina, researchers say. The findings...
|
|
|
Garlic-based Drug can Treat Diabetes Types I and II
Pharma Companies Can Influence Medical Journalists By Offering Sops: Report(21 min ago) Malaysia Muslims Adviced Not To Practice Yoga(42 min ago) Early Testing, Treatment Can Prevent Illness, Death In HIV-Positive Babies(57 min ago)...
|
|
|
Accuracy of Primary Care Clinicians in Screening for Diabetic Retinopathy Using Single-Image Retinal Photograp
_ Accuracy of Primary Care Clinicians in Screening for Diabetic Retinopathy Using Single-Image Retinal Photograp.
|
|
|
Age of Diabetes Onset and Risk for Retinopathy
Wong J, Molyneaux L, Constantino M, et al.Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care. 2008;31(10):1985-1990. The age at which a...
|
|
|
Laser photocoagulation still standard of care for diabeticmaculopathy
Source: Ophthalmology Times Meeting E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License |Discuss On Sermo The Early Treatment Diabetic Retinopathy Study (ETDRS) laser is still the standard of care of diabetic maculopathy...
|
|
|
Timing Is Everything: Age of Onset Influences Long-term Retinopathy Risk in Type 2 Diabetes, Independent of Tr
_ Timing Is Everything: Age of Onset Influences Long-term Retinopathy Risk in Type 2 Diabetes, Independent of Tr.
|
|
|
Blood Sugar Control Helps Diabetics Preserve Sight
FRIDAY, Nov.14 (HealthDay News) -- Maintaining good control over one's blood sugar levels can help people with type 1 diabetes better avoid retinopathy, a serious disorder that damages the eye's retina, researchers say. The findings...
|
|
|
Dietary supplement combats oxidative stress associated withretinopathy
Source: Ophthalmology Times Meeting E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License |Discuss On Sermo The launch of a specialized dietary supplement (DiaVis, ScienceBased Health) to support the visual and overall health of...
|
|
|
Dietary supplement combats oxidative stress associated with retinopathy
Source: Ophthalmology Times Meeting E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License |Discuss On Sermo The launch of a specialized dietary supplement (DiaVis, ScienceBased Health) to support the visual and overall health of...
|
|
|
Laser photocoagulation still standard of care for diabetic maculopathy
Source: Ophthalmology Times Meeting E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License |Discuss On Sermo The Early Treatment Diabetic Retinopathy Study (ETDRS) laser is still the standard of care of diabetic maculopathy...
|
|
|
ASN: Candesartan Does Not Prevent Microalbuminuria in Diabetes
PHILADELPHIA, Nov.10 -- In patients with diabetes, the angiotensin receptor blocker candesartan (Atacand) had no effect on the development of microalbuminuria, a post hoc analysis showed. Rates of microalbuminuria did not differ...
|
|
|
Ellex Announces Six-Month Results on Retina Regeneration Therapy
ATLANTA, Nov.9 /PRNewswire/ -- Ellex Medical Lasers Limited (ASX: ELX), a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, today announced the six-month clinical study results for the groundbreaking...
|
|
|
Ellex Announces Six-Month Results on Retina Regeneration Therapy
ATLANTA, Nov.9 /PRNewswire/ -- Ellex Medical Lasers Limited , a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, today announced the six-month clinical study results for the groundbreaking treatment...
|
|
|
Ellex Announces Six-Month Results on Retina Regeneration Therapy
ATLANTA, Nov.9 /PRNewswire/ -- Ellex Medical Lasers Limited , a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, today announced the six-month clinical study results for the groundbreaking treatment...
|
|
|
Tube versus Trabeculectomy Study: 3-year results
Source: Ophthalmology Times Meeting E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License |Discuss On Sermo Three-year results from the Tube versus Trabeculectomy Study showed that tube-shunt surgery was more likely than...
|
|
|
AAO: Education products unveiled at AAO meeting
Source: Ophthalmology Times Meeting E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License |Discuss On Sermo The 2008 annual meeting of the American Academy of Ophthalmology (AAO) is featuring several new and forthcoming patient...
|
|
|
Accuracy of Primary Care Clinicians in Screening for Diabetic Retinopathy Using Single-Image Retinal Photograp
_ Accuracy of Primary Care Clinicians in Screening for Diabetic Retinopathy Using Single-Image Retinal Photograp.
|
|
|
Fight Obesity and Diabetes With the New 'Red Wine' Drug
(9 min ago) Islamic Militia Stone 13-year-old Girl to Death for adultery(14 min ago) Schizophrenics Lack Vital Brain Receptor(17 min ago) Doubling in Cancer Cases Predicted by 2050 Due to Rising Obesity Rates(31 min ago) Why the Dengue Virus...
|
|
|
Lysyl Oxidase Activity in the Ocular Tissues and the Role of LOX in Proliferative Diabetic Retinopathy and Rhe
About MDLinx| Contact | Advertise with MDLinx | Site Map | Privacy Policy | Terms of Use | Sign Up For Newsletters | Recommend this Site English| Espaol | Franais | Deutsch | | cc | Norsk | Nederlands | Portugus | Italiano 1999-2008 MDLinx,...
|
|
|
Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
RICHMOND, Va., Oct.30 /PRNewswire-FirstCall/ -- Insmed Inc. , a developer of follow-on biologics and biopharmaceuticals, today reported results for the third quarter and nine-months ended September 30, 2008. Recent Company Highlights ...
|
|
|
'Bad Behavior' of Good Genes Trigger Type-1 Diabetes Study
(14 min ago) New Zealand Researchers Create Safe Vaccine Booster(26 min ago) Simple Blood Test to Predict Obesity In the Offing(1 hr ago) Consuming Peanut at Infancy may Help to Keep Allergy at Bay(1 hr ago) Common Household Objects are Key...
|
|
|
Treating Neovascular Peripheral Retinal Diseases
MARENA PATRONAS, MD JOSEPH M.CONEY, MD LAWRENCE J. SINGERMAN, MD, FACS Pathological processes in the peripheral retina have attracted the attention of both clinical investigators and practicing ophthalmologists for many years.
|
|
|
The Latest Trends in Retinal Vein Occlusions
ALEXANDER J.BRUCKER, MD NETAN CHOUDHRY, MD Occlusive retinal vascular disease is not uncommon. Central retinal vein occlusion (CRVO) is the second most common vision-impairing vascular disorder of the retina following diabetic...
|
